Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients
Conditions:   Schizophrenia; Psychosis;   Metabolic Syndrome;   Flupentixol;   Antipsychotic Agents;   Central Nervous System Diseases;   Clinical Therapy;   Olanzapine;   Quetiapine Interventions:   Drug: Flupentixol;   Drug: Multi-acting receptor-targeted antipsychotics (MARTAs) Sponsor:   Taichung Veterans General Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 24, 2021 Category: Research Source Type: clinical trials